Abstract:Breast metastases from distant carcinoma are infrequent, and cervix carcinoma is rarely the primary lesion. We describe the first case of a cervical squamous cell carcinoma with breast metastasis mimicking an inflammatory breast cancer in a 74-year-old woman. Seventeen months after the treatment of a primary tumor, the patient developed breast lesions looking like an inflammatory breast tumor. After a 1-year delay due to the patient’s refusal, pathological examination and immunohistochemistry confirmed the dia… Show more
“…Several other sites of metastasis, besides the breast, have already been described in the literature as due to the increase in survival time of patients, resulting from the multidisciplinary treatment for primary tumor 6 . Figure 6.…”
Section: Discussionmentioning
confidence: 99%
“…The primary tumors that spread more often to the breast are, in descending order of frequency: melanoma, lymphoma, lung cancer, soft tissue sarcoma, ovarian carcinoma, gastrointestinal and genitourinary cancers 6 .…”
Section: Discussionmentioning
confidence: 99%
“…Regarding the immunohistochemical study, no marker is 100% sensitive or specific for any type of tumor 5 . Breast metastases do not normally express estrogen, progesterone and HER2 protein receptors 6 . The combination of cytokeratin 7 and cytokeratin 20 is useful when categorizing carcinomas 12 .…”
Section: Discussionmentioning
confidence: 99%
“…Secondary breast tumors can occur due to tumors in the contralateral breast or originate in almost any extramammary site 5 . However, breast's metastatic involvement is also very rare, representing from 0.5 to 1.5% of all malignant breast neoplasms in clinical series and 6.6% in autopsies series 6 . The types most frequently associated with breast metastases spots are: skin (melanoma), lung, prostate, intestine (intestinal carcinoid), ovary, stomach, renal cell, thyroid and soft tissue (sarcomas) 5 .…”
O câncer de mama é o tumor maligno mais frequente em mulheres, no entanto o carcinoma epidermoide primário da mama é muito raro. Vários critérios patológicos são necessários para estabelecer o diagnóstico de carcinoma de células escamosas (CEC) primário da mama: 1) a origem do tumor deve ser independente da pele sobrejacente e do mamilo; 2) o componente infiltrante deve ser predominantemente de tipo escamoso (>90%); 3) nenhum outro elemento neoplásico invasivo, como ductal ou mesenquimal, deve estar presente no tumor; 4) um sítio primário de CEC deve ter sido excluído. Já os tumores secundários na mama podem ocorrer em razão de tumores na mama contralateral ou ter origem em praticamente qualquer sítio extramamário. As metástases para mama, normalmente, não expressam receptores de estrogênio nem de progesterona ou proteína Human Epidermal growth factor Receptor-type 2 (HER2). O prognóstico, na maioria dos casos, é pobre e o tratamento paliativo, com base na terapia sistêmica adaptada ao câncer primário, às vezes completada pelo tratamento locorregional da lesão mamária. O presente trabalho relata o caso de uma mulher previamente tratada por carcinoma escamocelular de pele, evoluindo com metástase para mama, porém mais estudos sobre esses tumores raros são necessários para aumentar o conhecimento e melhorar os resultados obtidos por esses pacientes.
“…Several other sites of metastasis, besides the breast, have already been described in the literature as due to the increase in survival time of patients, resulting from the multidisciplinary treatment for primary tumor 6 . Figure 6.…”
Section: Discussionmentioning
confidence: 99%
“…The primary tumors that spread more often to the breast are, in descending order of frequency: melanoma, lymphoma, lung cancer, soft tissue sarcoma, ovarian carcinoma, gastrointestinal and genitourinary cancers 6 .…”
Section: Discussionmentioning
confidence: 99%
“…Regarding the immunohistochemical study, no marker is 100% sensitive or specific for any type of tumor 5 . Breast metastases do not normally express estrogen, progesterone and HER2 protein receptors 6 . The combination of cytokeratin 7 and cytokeratin 20 is useful when categorizing carcinomas 12 .…”
Section: Discussionmentioning
confidence: 99%
“…Secondary breast tumors can occur due to tumors in the contralateral breast or originate in almost any extramammary site 5 . However, breast's metastatic involvement is also very rare, representing from 0.5 to 1.5% of all malignant breast neoplasms in clinical series and 6.6% in autopsies series 6 . The types most frequently associated with breast metastases spots are: skin (melanoma), lung, prostate, intestine (intestinal carcinoid), ovary, stomach, renal cell, thyroid and soft tissue (sarcomas) 5 .…”
O câncer de mama é o tumor maligno mais frequente em mulheres, no entanto o carcinoma epidermoide primário da mama é muito raro. Vários critérios patológicos são necessários para estabelecer o diagnóstico de carcinoma de células escamosas (CEC) primário da mama: 1) a origem do tumor deve ser independente da pele sobrejacente e do mamilo; 2) o componente infiltrante deve ser predominantemente de tipo escamoso (>90%); 3) nenhum outro elemento neoplásico invasivo, como ductal ou mesenquimal, deve estar presente no tumor; 4) um sítio primário de CEC deve ter sido excluído. Já os tumores secundários na mama podem ocorrer em razão de tumores na mama contralateral ou ter origem em praticamente qualquer sítio extramamário. As metástases para mama, normalmente, não expressam receptores de estrogênio nem de progesterona ou proteína Human Epidermal growth factor Receptor-type 2 (HER2). O prognóstico, na maioria dos casos, é pobre e o tratamento paliativo, com base na terapia sistêmica adaptada ao câncer primário, às vezes completada pelo tratamento locorregional da lesão mamária. O presente trabalho relata o caso de uma mulher previamente tratada por carcinoma escamocelular de pele, evoluindo com metástase para mama, porém mais estudos sobre esses tumores raros são necessários para aumentar o conhecimento e melhorar os resultados obtidos por esses pacientes.
“…The clinical and pathologic features of metastatic gynecologic primary tumours (gpts) can mimic metastatic disease from other sites [8][9][10][11] , complicating the task of effectively managing affected patients-for example, by quickly referring them to specialized gynecologic oncology services. Accurate diagnosis of gpt cancers might improve survival by allowing patients to benefit from a growing arsenal of effective site-specific (targeted) therapies 4,12 .…”
Objective We estimated the frequency of occult gynecologic primary tumours (gpts) in patients with metastatic cancer from an uncertain primary and evaluated the effect on disease management and overall survival (os).
MethodsWe used Manitoba administrative health databases to identify all patients initially diagnosed with metastatic cancer during 2002−2011. We defined patients as having an "occult" primary tumour if the primary was classified at least 6 months after the initial diagnosis. Otherwise, we considered patients to have "obvious" primaries. We then compared clinicopathologic and treatment characteristics and 2-year os for women with occult and with obvious gpts. We used Cox regression adjustment and propensity score methods to assess the effect on os of having an occult gpt.Results Among the 5953 patients diagnosed with metastatic cancer, occult primary tumours were more common in women (n = 285 of 2552, 11.2%) than in men (n = 244 of 3401, 7.2%). In women, gpts were the most frequent occult primary tumours (n = 55 of 285, 19.3%). Compared with their counterparts having obvious gpts, women with occult gpts (n = 55) presented with similar histologic and metastatic patterns but received fewer gynecologic diagnostic examinations during diagnostic work-up. Women with occult gpts were less likely to undergo surgery, waited longer for radiotherapy, and received a lesser variety of chemotherapeutic agents. Having an occult compared with an obvious gpt was associated with decreased os (hazard ratio: 1.62; 95% confidence interval: 1.2 to 2.35). Similar results were observed in adjusted analyses.
ConclusionsIn women with metastatic cancer from an uncertain primary, gpts constitute the largest clinical entity.Accurate diagnosis of occult gpts early in the course of metastatic cancer might lead to more effective treatment decisions and improved survival outcomes.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.